https://www.selleckchem.com/products/fht-1015.html
5%, 26.4% and 5.88%, respectively. No men with primary hypogonadism were identified in our sample. Those with compensated hypogonadism had also higher FSH levels (7.8mUI/mL, P.0001). In our study population of men with SCD, a high prevalence of compensated hypogonadism was identified, which is a controversial and distinct clinical entity that warrants monitoring and further research. In our study population of men with SCD, a high prevalence of compensated hypogonadism was identified, which is a controversial and distinct clini
Like
Comment
Share
